↓ Skip to main content

Dove Medical Press

Role of rituximab in first-line treatment of chronic lymphocytic leukemia

Overview of attention for article published in Therapeutics and Clinical Risk Management, December 2010
Altmetric Badge

Mentioned by

patent
3 patents

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
61 Mendeley
Title
Role of rituximab in first-line treatment of chronic lymphocytic leukemia
Published in
Therapeutics and Clinical Risk Management, December 2010
DOI 10.2147/tcrm.s5855
Pubmed ID
Authors

Jeffrey Bryan, Gautam Borthakur

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 61 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Romania 1 2%
Unknown 60 98%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 17 28%
Researcher 9 15%
Other 5 8%
Student > Ph. D. Student 5 8%
Student > Doctoral Student 3 5%
Other 8 13%
Unknown 14 23%
Readers by discipline Count As %
Medicine and Dentistry 26 43%
Pharmacology, Toxicology and Pharmaceutical Science 7 11%
Agricultural and Biological Sciences 5 8%
Biochemistry, Genetics and Molecular Biology 4 7%
Engineering 2 3%
Other 3 5%
Unknown 14 23%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 February 2024.
All research outputs
#8,534,528
of 25,373,627 outputs
Outputs from Therapeutics and Clinical Risk Management
#461
of 1,323 outputs
Outputs of similar age
#57,625
of 190,758 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#4
of 6 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,323 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has gotten more attention than average, scoring higher than 55% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 190,758 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 24th percentile – i.e., 24% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 6 others from the same source and published within six weeks on either side of this one. This one has scored higher than 2 of them.